32
nanotimes
Companies Facts
and our company, as we are included on a list of ho- norees that include some of the best scientific minds and business leaders in the nation. It is both inspiring and humbling to appear on this list of nanotechnolo- gy leaders who are creating a more competitive and innovative nation.”
In June of 2011, Nanomech announced the creation of nGlide, a lubrication additive that tremendously improves the efficiency and performance of machines and engines. Nanomech has created a pipeline of innovative product lines, such as Tufftek, Element X, and nGuard to position the company as a multi-plat- form leader in the nanotechnology innovation and commercialization fields.
http://www.nanomech.biz http://www.nanobca.org
I
n the fiscal 2011, Nanometrics‘ (NASDAQ: NANO) revenue increased to $230.1 million (+22%)
from $188.1 million in fiscal 2010. Gross margin was 53.5%, a decline compared to 54.4% in 2010, primarily due to product mix and the impact of lower factory absorption in the fourth quarter of 2011. GAAP net income was $28.7 million or $1.22 per share, compared to $55.9 million or $2.43 per share in the 2010. GAAP net income in 2011 included the negative impact of approximately $2.0 million in acquisition-related costs and $2.5 million for set- tlement of litigation with KLA-Tencor, while 2010 results reflected the favorable impact of the release of $18.2 million in income tax asset valuation allo- wances. Non-GAAP net income was $32.7 million or $1.39 per share, compared to $39.0 million or $1.70
per share in 2010. At December 31, 2011, Nanome- trics had $97.7 million in cash and cash equivalents and $160.6 million in working capital. Stockholders‘ equity, excluding intangible assets, was $183.6 milli- on, or $7.92 per share based on 23.2 million shares outstanding at year end.
Due to the improvement in business conditions since last quarter, management expects revenues in the range of $52 to $55 million, gross margin in the ran- ge of 47% to 50%, and operating income margin in the range of 5% to 10% for the first quarter of 2012.
http://www.nanometrics.com T
he Michigan State University spin-out company nanoRETE will develop and commercialize an
inexpensive test for handheld biosensors to detect a broad range of threats such as
E.coli, Salmonella, anthrax and tuberculosis. A significant leap forward in detection and diagnostic technology, it utilizes novel nanoparticles with magnetic, polymeric and electrical properties developed by Evangelyn Alocilja, MSU professor of biosystems and agricultural engi- neering and chief scientific officer of nanoRETE.
“Although the technology originates from research for biodefense applications, its potential reaches far beyond the initial scope,” said Fred Beyerlein, CEO of nanoRETE. “Our X-MARK platform-based tech- nology has the ability to detect multiple pathogens or toxins at one time, in a rapid, point-of-use, cost- effective manner. Imagine the potential applications for food growers, packagers or sellers. Contaminated food or water could be quickly identified, isolated and resolved before reaching the ultimate consu-
12-01 :: January 2012
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97